Table 2.
Pharmacokinetic parameters of scutellarin, rosuvastatin, and rosuvastatin under combination treatment (n = 6, data presented as mean ± standard deviation).
| Pharmacokinetic parameters | Rosuvastatin treatment (10 mg/kg) | Combination treatment: rosuvastatin + scutellarin | P value |
|---|---|---|---|
| Half life (t1/2, h) | 4.47 ± 1.31 | 4.76 ± 1.53 | 0.731 |
| Tmax(h) | 2.05 ± 0.660 | 2.16 ± 0.582 | 0.765 |
| Cmax(ng/mL) | 545 ± 143 | 846 ± 202* | 0.0153 |
| Clearance rate(ml/h/·kg) | 501 ± 69.0 | 307 ± 42.1** | 0.000 |
| AUC0-last (ng·/h·ml) | 2.94 × 103 ± 854 | 4.74 × 103 ± 1.22 × 103* | 0.0161 |
| AUC0-∞ (ng·/h·ml) | 2.96 × 103 ± 896 | 4.76 × 103 ± 1.23 × 103* | 0.0223 |
Compared groups: rosuvastatin treatment vs. combination treatment (rosuvastatin + scutellarin). *Indicates difference compared with the rosuvastatin alone group (P < 0.05), **indicates great difference compared with the rosuvastatin alone group (P < 0.01).